Managing chronic disease in Ireland: Hospital admission rates and clinical outcomes in a large ulcerative colitis population

  • A. N. Desmond
  • , F. Shanahan

Research output: Contribution to journalArticlepeer-review

Abstract

Background Health care planning demands a detailed knowledge of the course of chronic diseases in the Irish population. This study describes hospital admission rates, medication use and outcomes in a large cohort of patients with ulcerative colitis attending a tertiary referral centre in Ireland. Method Four hundred and twenty-four patients who attended during the 18-year period from January 1991 to January 2009 were identified. Baseline demographics, hospital admission, medications required, extent of colitis and date of colectomy were recorded. Results More than half (55.4%) of the patients were managed exclusively in an outpatient setting throughout diagnosis and follow-up. Systemic corticosteroids, thiopurines and infliximab were required by 70, 29.5 and 5% of the patients, respectively. Overall 5-year colectomy rate due to failure of medical therapy was 15.8%. Independent predictors of colectomy were hospital admission at first presentation (odds ratio 3.6, p < 0.0001) and pancolitis at diagnosis (odds ratio 2.3, p < 0.01). Conclusions The majority of patients with colitis have an uncomplicated disease course and do not require thiopurines, biologic agents or hospital admission. Principal management at a primary care level may be appropriate in many cases. Colectomy rates at a specialist centre in Ireland compare favourably with international figures.

Original languageEnglish
Pages (from-to)65-71
Number of pages7
JournalIrish Journal of Medical Science
Volume181
Issue number1
DOIs
Publication statusPublished - Mar 2012

Keywords

  • Colectomy
  • Inflammatory bowel disease
  • Infliximab
  • Thiopurines
  • Ulcerative colitis

Fingerprint

Dive into the research topics of 'Managing chronic disease in Ireland: Hospital admission rates and clinical outcomes in a large ulcerative colitis population'. Together they form a unique fingerprint.

Cite this